
Fact Check Analysis: FDA expands approval of Moderna’s RSV vaccine to some adults under age 60
Introduction The recent FDA expansion of Moderna’s RSV vaccine approval to certain adults under 60 has raised questions about whether this decision was health-driven or profit-motivated. A user specifically asked